Joyce Sanders

4.0k total citations · 1 hit paper
73 papers, 1.5k citations indexed

About

Joyce Sanders is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Joyce Sanders has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 17 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Joyce Sanders's work include Cancer Immunotherapy and Biomarkers (16 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Cancer Treatment Studies (10 papers). Joyce Sanders is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Cancer Treatment Studies (10 papers). Joyce Sanders collaborates with scholars based in Netherlands, United States and Belgium. Joyce Sanders's co-authors include Annegien Broeks, Theo J. M. Ruers, John B.A.G. Haanen, Sabine C. Linn, Christian U. Blank, Henricus J. C. M. Sterenborg, Jeroen de Jong, Mark Opdam, Niels F. M. Kok and Helena M. Dekker and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Joyce Sanders

72 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer

2021 195 citations Marjolein de Bruijn, Lisanne M. Roelofsen et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joyce Sanders Netherlands	23	718	392	324	316	274	73	1.5k
Arantza Fariña Sarasqueta Netherlands	22	1.0k 1.4×	437 1.1×	366 1.1×	227 0.7×	383 1.4×	83	1.8k
Attila Marcell Szász Hungary	24	611 0.9×	594 1.5×	306 0.9×	122 0.4×	236 0.9×	127	1.7k
Rahul Ladwa Australia	16	986 1.4×	525 1.3×	365 1.1×	519 1.6×	156 0.6×	93	1.7k
Heather Dawson Switzerland	28	1.3k 1.8×	400 1.0×	337 1.0×	240 0.8×	393 1.4×	99	2.1k
Jeffrey Chun Tatt Lim Singapore	22	680 0.9×	505 1.3×	183 0.6×	413 1.3×	110 0.4×	52	1.5k
Franco Di Filippo Italy	25	847 1.2×	477 1.2×	306 0.9×	254 0.8×	412 1.5×	80	1.9k
Catherine Genestie France	26	668 0.9×	701 1.8×	470 1.5×	226 0.7×	423 1.5×	164	2.6k
Marie‐Christine Mathieu France	25	978 1.4×	461 1.2×	403 1.2×	160 0.5×	184 0.7×	63	2.1k
Neda A. Moatamed United States	17	609 0.8×	359 0.9×	176 0.5×	127 0.4×	321 1.2×	79	1.3k
Kris Ylaya United States	25	816 1.1×	1.0k 2.7×	362 1.1×	444 1.4×	212 0.8×	45	2.0k

Countries citing papers authored by Joyce Sanders

Since Specialization

Citations

This map shows the geographic impact of Joyce Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Sanders more than expected).

Fields of papers citing papers by Joyce Sanders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Sanders. The network helps show where Joyce Sanders may publish in the future.

Co-authorship network of co-authors of Joyce Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce Sanders. A scholar is included among the top collaborators of Joyce Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce Sanders. Joyce Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López‐Yurda, Marta, Richard A. Scolyer, B. van de Wiel, et al.. (2025). LBA57 Two-year clinical update and first biomarker analyses of the phase III NADINA trial comparing neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable stage III melanoma. Annals of Oncology. 36. S1600–S1601.

Sanders, Joyce, Marie-Jeanne T. F. D. Vrancken Peeters, Frederieke van Duijnhoven, et al.. (2025). Toward real-time margin assessment in breast-conserving surgery with hyperspectral imaging. Scientific Reports. 15(1). 9556–9556. 3 indexed citations

Heinhuis, Kimberley M., Nikki S. IJzerman, Anne Miek Koenen, et al.. (2024). Propranolol monotherapy in angiosarcoma – A window-of-opportunity study (PropAngio). European Journal of Cancer. 202. 113974–113974. 4 indexed citations

Liefaard, Marte C., Anna van der Voort, Maartje van Seijen, et al.. (2024). Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade. npj Breast Cancer. 10(1). 29–29. 10 indexed citations

Mayayo‐Peralta, Isabel, Stefan Preković, Karianne Schuurman, et al.. (2023). Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1 – NDRG1 deregulation. Molecular Oncology. 18(1). 156–169. 5 indexed citations

Steenbruggen, Tessa G., Denise M. Wolf, Bram Thijssen, et al.. (2023). Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort. JCO Precision Oncology. 7(7). e2200670–e2200670. 1 indexed citations

Bodalal, Zuhir, Leon C. ter Beek, José G. van den Berg, et al.. (2023). Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases. Insights into Imaging. 14(1). 133–133. 10 indexed citations

Voort, Anna van der, Marte C. Liefaard, Mette S. van Ramshorst, et al.. (2022). Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival. The Breast. 65. 110–115. 7 indexed citations

Burgess, Earle F., Joyce Sanders, Chad Livasy, et al.. (2022). Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes. Urologic Oncology Seminars and Original Investigations. 40(8). 383.e1–383.e10. 2 indexed citations

10.

Steenbruggen, Tessa G., Michael Schaapveld, Hugo M. Horlings, et al.. (2021). Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer. JNCI Cancer Spectrum. 5(3). 18 indexed citations

11.

Bruijn, Marjolein de, Lisanne M. Roelofsen, Sanne H. Hendriks, et al.. (2021). An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nature Medicine. 27(7). 1250–1261. 195 indexed citations breakdown →

12.

Almekinders, Mathilde M., Michael Schaapveld, Bram Thijssen, et al.. (2021). Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ. npj Breast Cancer. 7(1). 31–31. 15 indexed citations

13.

Sanders, Joyce, et al.. (2020). A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve?. SHILAP Revista de lepidopterología. 2 indexed citations

14.

Opdam, Mark, Vincent van der Noort, Joyce Sanders, et al.. (2020). PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane. Journal of Cancer Research and Clinical Oncology. 146(11). 3013–3023. 6 indexed citations

15.

Cimino‐Mathews, Ashley, Yoni Lubeck, Mark Opdam, et al.. (2020). Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. European Journal of Cancer. 127. 240–250. 18 indexed citations

16.

Wit, Meike de, Robbert J.C. Slebos, Pien M. Delis‐van Diemen, et al.. (2020). Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. European Journal of Cancer. 144. 91–100. 13 indexed citations

17.

Singh, Abhishek A., Karianne Schuurman, Ekaterina Nevedomskaya, et al.. (2018). Optimized ChIP-seq method facilitates transcription factor profiling in human tumors. Life Science Alliance. 2(1). e201800115–e201800115. 28 indexed citations

18.

Vegt, Erik, Francine E.M. Voncken, Berthe M.P. Aleman, et al.. (2014). Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Clinical Nuclear Medicine. 39(10). 862–867. 35 indexed citations

19.

Kramer, Henk, Joyce Sanders, Wendy J. Post, Harry J.M. Groen, & Albert J.H. Suurmeijer. (2006). Analysis of cytological specimens from mediastinal lesions obtained by endoscopic ultrasound-guided fine-needle aspiration. Cancer. 108(4). 206–211. 28 indexed citations

20.

Dekker, Helena M., et al.. (2003). Best Cases from the AFIP. Radiographics. 23(2). 309–313. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact